In conversation with...

Follow In conversation with...
Share on
Copy link to clipboard

Lan-Lan Smith, Editor-in-Chief of The Lancet Haematology, and the journal’s authors explore their research and its impact on people’s health, health care, and health policy in this regular podcast.

The Lancet Haematology


    • Apr 28, 2025 LATEST EPISODE
    • monthly NEW EPISODES
    • 14m AVG DURATION
    • 55 EPISODES


    Search for episodes from In conversation with... with a specific topic:

    Latest episodes from In conversation with...

    Michael Northend on early rituximab monotherapy versus watchful waiting for advanced stage, asymptomatic, low tumour burden follicular lymphoma

    Play Episode Listen Later Apr 28, 2025 15:49


    Dr Michael Northend (University College London Hospitals NHS Foundation Trust, and Cancer Research UK & UCL Cancer Trials Centre, London, UK) joins us to discuss the long-term results of a randomised, phase 3 trial on early rituximab monotherapy versus watchful waiting for advanced stage, asymptomatic, low tumour burden follicular lymphoma.Read the full article:https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(25)00034-1/fulltext?dgcid=buzzsprout_icw_podcast_28-04-25_lanhaeContinue this conversation on social!Follow us today at...https://thelancet.bsky.social/https://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

    Joanne Verweij and Romy Pothof on fetal and neonatal alloimmune thrombocytopenia

    Play Episode Listen Later Mar 31, 2025 17:47


    Dr Romy Pothof and Prof Joanne Verweij join us to discuss their development of an international consensus on the diagnosis and treatment of fetal and neonatal alloimmune thrombocytopenia.Read the full article:https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(25)00029-8/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhaeContinue this conversation on social!Follow us today at...https://thelancet.bsky.social/https://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

    Helene Schoemans, Elke Stienissen, and Kathy Goris on a consulting a patient advisory board to understand unmet needs of patients with GVHD in Europe

    Play Episode Listen Later Mar 3, 2025 27:06


    Prof Helene Schoemans, Elke Stienissen, and Kathy Goris join us to discuss the importance of consulting a patient advisory board to understand unmet needs of patients with GVHD in Europe.Continue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

    Dawn Swan on air pollution and venous thromboembolism

    Play Episode Listen Later Jan 29, 2025 15:02


    Dr Dawn Swan joins us to discuss current knowledge and future perspectives on the possible association between air pollution and venous thromboembolism.Read the full article:https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(24)00291-6/fulltext?dgcid=buzzsprout_icw_podcast_general_lanhaeContinue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

    Leslie Skeith on low-dose aspirin for postpartum venous thromboembolism prophylaxis

    Play Episode Listen Later Jan 16, 2025 16:03


    Dr Leslie Skeith joins us to discuss the PARTUM pilot trial, comparing low-dose aspirin versus placebo in postpartum venous thromboembolism.Continue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

    Neema Mayor and Caitlin Farrow on impact of patient ethnicity on haematopoeietic cell transplantation outcome in the United Kingdom

    Play Episode Listen Later Dec 3, 2024 17:53


    Dr Neema Mayor and Dr Caitlin Farrow from the Anthony Nolan Research Institute join us to discuss the findings of their study on the impact of patient ethnicity on haematopoietic cell transplantation outcomes in the United Kingdom.Continue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

    Lancet Haematology 10 year anniversary - meet the editors

    Play Episode Listen Later Oct 2, 2024 47:21


    In a special 10 year anniversary podcast, Lan-Lan Smith, Yaiza del Pozo Martin, and Emma Cookson, the editorial team behind The Lancet Haematology, reflect on the last decade and give some insights into the editorial processes at The Lancet Group.Read our Editorial:https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(24)00289-8/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhaeContinue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

    Matteo Della Porta on the phase 3 COMMANDS trial examining luspatercept versus epoetin alfa in patients with lower-risk myleodysplastic syndrome

    Play Episode Listen Later Aug 22, 2024 8:08


    Professor Matteo Giovanni Della Porta joins us to discuss the primary analysis of the phase 3 COMMANDS trial comparing luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndrome patients.Continue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

    Kim Linton on follicular lymphoma

    Play Episode Listen Later Aug 7, 2024 9:48


    Dr Kim Linton joins us to discuss the EPCORE NHL-1 trial testing monotherapy with the bispecific antibody epcoritamab for patients with relapsed or refractory follicular lymphoma.Read the full article:https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(24)00166-2?dgcid=buzzsprout_tlv_podcast_generic_lanhaeContinue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

    Judy Truong on ferritin reference levels and iron deficiency

    Play Episode Listen Later Aug 5, 2024 11:17


    Dr Judy Truong join us to discuss ferritin reference intervals and how adoption of evidence-based ferritin clinical decision limits can help clinicians detect and treat iron deficiency, minimising propagation of related health inequity and social injustice in medicine.Read the full article:https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(24)00103-0?dgcid=buzzsprout_tlv_podcast_generic_lanhaeContinue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

    Johannes Schetelig on remission induction versus immediate allogeneic HSCT for patients with AML

    Play Episode Listen Later Jul 16, 2024 14:11


    Professor Johannes Schetelig joins us to discuss the results of the ASAP phase 3 trial comparing remission induction with immediate allogeneic haematopoietic stem cell transplantation for patients with relapsed or poor responsive acute myeloid leukaemia.Read the full article:https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(24)00065-6/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhaeContinue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

    Banu Aygun on sickle cell anaemia

    Play Episode Listen Later May 23, 2024 11:13


    Professor Banu Aygun joins us to discuss the REACH trial testing hydroxyurea dose optimisation for children with sickle cell anaemia in sub-Saharan Africa.Read the full article:https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(24)00078-4?dgcid=buzzsprout_icw_podcast_generic_lanhaeContinue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

    Sabine Braat and Katherine Fielding on haemoglobin thresholds to define anaemia

    Play Episode Listen Later Mar 1, 2024 18:06


    Dr Sabine Braat and Dr Katherine Fielding join us to discuss their study presenting new haemoglobin thresholds for defining anaemia.Read the full article:https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(24)00030-9/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhaeContinue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

    Elisabeth Schorb on the MARTA phase 2 trial

    Play Episode Listen Later Feb 29, 2024 9:23


    Doctor Elisabeth Schorb joins us to discuss the MARTA phase 2 trial, treating older, fit patients with primary diffuse large B-cell CNS lymphoma with high-dose chemotherapy and autologous stem-cell transplantation.Read the full article:https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(23)00371-X/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhaeContinue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

    Stephan Ehl on paediatric autoimmune lymphoproliferative immunodeficiencies

    Play Episode Listen Later Jan 31, 2024 13:03


    Professor Stephan Ehl joins us to discuss a prospective observational study on paediatric autoimmune lymphoproliferative immunodeficiencies.Read the full article:https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(23)00638-1/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanoncContinue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

    Dr Sarah O'Brien on the PREVAPIX-ALL trial

    Play Episode Listen Later Dec 20, 2023 13:50


    Dr Sarah O'Brien joins Lan-Lan Smith to discuss results of the phase 3 PREVAPIX-ALL trial, which compares direct oral anticoagulant apixaban to low-molecular-weight-heparin for the prevention of venous thromboembolism in children with newly diagnosed acute lymphoblastic leukaemia or lymphoma.Read the full article:https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(23)00314-9/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhaeContinue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

    Enrico Lopriore on haemolytic disease of the fetus and newborn

    Play Episode Listen Later Nov 29, 2023 12:33


    Professor Enrico Lopriore joins us to discuss a trial testing darbepoetin alfa to prevent postnatal anaemia in infants with haemolytic disease of the fetus and newborn.Read the full article:https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(23)00285-5/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhaeContinue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

    Meletios Dimopoulos on relapsed and refractory multiple myeloma

    Play Episode Listen Later Oct 3, 2023 11:00


    Professor Meletios Dimopoulos joins us to discuss two trials for patients with relapsed and refractory multiple myeloma - the first report of the DREAMM-3 phase 3 and long-term follow-up of the APOLLO phase 3 trial.Read the full article:https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(23)00243-0/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhaeContinue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

    Eric Ohuma on haemoglobin concentrations and neonatal outcomes

    Play Episode Listen Later Aug 29, 2023 16:27


    Dr Eric Ohuma joins us to tell us about a study recently published in The Lancet Haematology on the association between maternal haemoglobin concentrations and maternal and neonatal outcomes.Read the full article:https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(23)00170-9/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhaeContinue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

    Margaret Ragni on tranexamic acid to treat heavy menstrual bleeding

    Play Episode Listen Later Jul 31, 2023 13:13


    Professor Margaret Ragni joins us to discuss the VWDMin study, published in The Lancet Haematology. In this phase 3, randomised, crossover trial, recombinant von Willebrand factor and tranexamic acid are used to treat heavy menstrual bleeding in patients with mild and moderate von Willebrand disease in the USA. Read the full article:https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(23)00119-9/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhaeContinue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

    Oreofe Odejide and Thomas Kuczmarski on mental health and lymphoma

    Play Episode Listen Later Jul 3, 2023 16:32


    Dr Odejide and Dr Kuczmarski tell us about a study recently published in The Lancet Haematology on the effect of pre-existing mental health conditions on survival in patients with diffuse large B-cell lymphoma.Read the full article:https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(23)00094-7/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhaeContinue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

    Alok Srivastava on fitusiran for patients with haemophilia A and B

    Play Episode Listen Later Mar 29, 2023 18:41


    Professor Alok Srivastava tells us about two clinical trials being published in The Lancet and The Lancet Haematology on a new siRNA therapy called fitusiran for patients with haemophilia A and B.Read the two trials:Efficacy and safety of fitusiran prophylaxis in people with haemophilia A or haemophilia B with inhibitors (ATLAS-INH)https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)00284-2/fulltext?dgcid=buzzsprout_icw_podcast_buzzsprout_generalFitusiran prophylaxis in people with severe haemophilia A or haemophilia B without inhibitors (ATLAS-A/B)https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(23)00037-6/fulltext?dgcid=buzzsprout_icw_podcast_buzzsprout_generalContinue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

    Emmanuela E Ambrose on stroke prevention in children with sickle cell disease

    Play Episode Listen Later Mar 2, 2023 11:31


    Dr Emmanuela E Ambrose tells us about the SPHERE trial on hydroxyurea dose escalation for primary stroke prevention in children with sickle cell disease in TanzaniaRead the full article:Hydroxyurea with dose escalation for primary stroke risk reduction in children with sickle cell anaemia in Tanzania (SPHERE)Continue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

    Sumit Gupta on racial and ethnic disparities in leukaemia survival outcomes

    Play Episode Listen Later Jan 30, 2023 22:10


    Dr Sumit Gupta discusses how racial and ethnic disparities affect survival outcomes of children and young adults with acute lymphocytic leukaemia.Read the full article:Racial and ethnic disparities in childhood and young adult acute lymphocytic leukaemiaContinue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

    Xiao-Jun Huang on cellular therapy in China

    Play Episode Listen Later Nov 28, 2022 28:10


    Professor Xiao-Jun Huang discusses this Lancet Haematology series on Cellular Therapy in China, covering the history, current research challenges, and future of HSCT and CAR T-cell therapies in China.Read the Series papers:Cellular therapy in China

    Glenn Pierce on haemophilia care in LMICs

    Play Episode Listen Later Aug 30, 2022 34:55


    Dr Glenn Pierce discusses the World Federation of Hemophilia's Humanitarian Aid Program which provides access to haemophilia care in low-income and lower-middle-income countries.Read the full Review:Achieving access to haemophilia care in low-income and lower-middle-income countries

    Amy DeZern on the link between myelodysplastic syndrome and autoimmune disorders

    Play Episode Listen Later Jun 30, 2022 12:50


    Dr Amy DeZern discusses the link between myelodysplastic syndrome and autoimmune disorders and the need for a multidisciplinary approach for the treatment of patients who have both.Read the full article:Myelodysplastic syndrome and autoimmune disorders: two sides of the same coin?

    Nicholas Crombie and Gavin Perkins on resuscitation with blood products compared with saline

    Play Episode Listen Later Mar 7, 2022 15:05


    Dr Nicholas Crombie and Professor Gavin Perkins discuss their randomised phase 3 trial in which they investigated resuscitation with blood products compared with saline in patients with trauma-related haemorrhagic shock receiving prehospital care. 

    Fredrik Schjesvold on OCEAN phase 3

    Play Episode Listen Later Jan 31, 2022 12:24


    Dr Fredrik Schjesvold discusses the results of the OCEAN phase 3 trial testing melflufen or pomalidomide plus dexamethasone for patients with multiple myeloma refractory to lenalidomide. Read the full article:Melflufen or pomalidomide plus dexamethasone for patients with multiple myeloma refractory to lenalidomide (OCEAN)

    Jacob D Soumerai and Andrew D Zelenetz on the BOVen regimen for previously untreated patients with chronic lymphocytic leukaemia

    Play Episode Listen Later Nov 25, 2021 11:59


    Dr Jacob D Soumerai and Prof Andrew D Zelenetz discuss their phase 2 trial of the BOVen regimen and MRD-driven treatment discontinuation in previously untreated patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma.Read the full article:https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(21)00307-0/fulltext 

    Raul Cordoba on haematological malignancies in older people

    Play Episode Listen Later Nov 3, 2021 16:24


    Dr Raul Cordoba discusses the joint Series between The Lancet Healthy Longevity and The Lancet Haematology on haematological malignancies in older people.Read the full article:https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(21)00241-6/fulltext

    Obiageli Nnodu and Dennis Chao on child mortality from sickle cell disease in Nigeria

    Play Episode Listen Later Sep 21, 2021 9:03


    Professor Obiageli Nnodu and Dr Dennis Chao join acting Deputy Editor Emma Cookson to talk about their new study describing modelling of child mortality as a result of sickle cell disease in Nigeria. Read the full article:https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(21)00191-5/fulltext

    Zuguo Mei and Gary Brittenham on iron deficiency

    Play Episode Listen Later Jul 27, 2021 8:34


    Senior Assistant Editor Ben Burwood speaks with Dr Zuguo Mei (Division of Nutrition, Physical Activity, and Obesity, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA, USA)  and Dr Gary M Brittenham (Department of Pediatrics, College of Physicians and Surgeons, Columbia University, New York, NY, USA) about their work defining physiologically based serum ferritin thresholds for iron deficiency.Read the full article:https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(21)00168-X/fulltext

    Eugenia Trigoso Arjona (in Spanish) on nursing and haematological care

    Play Episode Listen Later May 11, 2021 29:11


    Para el Día International de la Enfermera, Eugenia Trigoso Arjona, enfermera coordinadora en el Hospital La Fe (Valencia, España) y presidenta del comité de educación de la European Society for Blood and Marrow Transplantation Nurses hablo con la Editora Yaiza del Pozo Martin sobre como las enfermeras pueden remodelar el futuro de la hematología. 

    Eugenia Trigoso Arjona (in English) on nursing and haematological care

    Play Episode Listen Later May 11, 2021 28:34


    To mark International Nurses Day, Eugenia Trigoso Arjona, nurse coordinator at Hospital La Fe (Valencia, Spain) and chair of the European Society for Blood and Marrow Transplantation Nurses Global Education Committee, joins acting Editor-in-Chief Yaiza del Pozo Martin to discuss how nurses can reshape the future of haematological care. 

    Nada Hamad on inclusion and diversity in haematology

    Play Episode Listen Later Feb 23, 2021 30:02


    A/Prof Nada Hamad (St Vincent's hospital, Sydney, Australia) joins Editor-in-Chief Dr Lan-Lan Smith to discuss inclusion and diversity in haematology-oncology and transplantation.  

    Dr Judith Boer on lymphoblastic leukaemia in children

    Play Episode Listen Later Dec 22, 2020 10:24


    Editor-in-Chief, Dr Lan-Lan Smith, speaks with Dr Judith Boer (Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands) about outcome of ABL-class acute lymphoblastic leukaemia in children in the pre-tyrosine kinase inhibitor era.Read the full article:https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(20)30353-7/fulltext

    Imatinib for paediatric leukaemia

    Play Episode Listen Later Dec 15, 2018 8:33


    Andrea Biondi joins The Lancet Haematology to discuss his work on imatinib as a treatment for paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia.

    Predicting the risk of adenoviraemia

    Play Episode Listen Later Aug 31, 2018 4:51


    Prashant Hiwarkar joins The Lancet Haematology to discuss his new paper, an investigation into whether serial faecal PCR monitoring can predict the risk of adenoviraemia and survival outcomes after HSCT.

    Adverse events in haematological malignancies

    Play Episode Listen Later Jun 12, 2018 12:31


    Lead author Gita Thanarajasingam joins The Lancet Haematology to discuss the new Commission on assessment and adverse event reporting in haematological malignancies.

    EPO blood doping and cycling: The Lancet Haematology: June 29, 2017

    Play Episode Listen Later Jun 30, 2017 8:34


    Jules Heuberger talks about his study on the effectiveness of EPO use by cyclists.

    Trauma-induced coagulopathy: The Lancet Haematology: June issue

    Play Episode Listen Later Jun 3, 2017 9:10


    Petra Innerhofer discusses reversal of trauma-induced coagulopathy using first-line coagulation factor concentrates or fresh frozen plasma.

    Childhood leukaemia survival (CONCORD-2): The Lancet Haematology: April 11, 2017

    Play Episode Listen Later Apr 12, 2017 5:46


    Audrey Bonaventure discusses her CONCORD-2 study, monitoring survival trends of two types of childhood leukaemia in 53 countries between 1995 and 2009.

    Superficial-vein thrombosis: The Lancet Haematology: February 15 2017

    Play Episode Listen Later Feb 16, 2017 10:27


    Jan Beyer discusses the SURPRISE trial of patients developing complications from superficial-vein thrombosis.

    Economic burden of blood disorders in Europe: The Lancet Haematology: July 21, 2016

    Play Episode Listen Later Jul 21, 2016 9:32


    Dr Jose Leal discusses a study of the costs related to malignant and non-malignant blood disorders in Europe in 2012.

    Castleman disease: The Lancet Haematology: March 17, 2016

    Play Episode Listen Later Mar 18, 2016 17:14


    David Fajgenbaum discusses a literature review to raise awareness of idiopathic multicentric Castleman disease, a poorly understood haematological disorder.

    Deep-vein thrombosis: The Lancet Haematology, October 29, 2015

    Play Episode Listen Later Oct 30, 2015 8:23


    Walter Ageno discusses the use of an algorithm combining limited and whole-leg compression ultrasonography to diagnose deep-vein thrombosis.

    Financial toxicity: The Lancet Haematology: September 17, 2015

    Play Episode Listen Later Sep 17, 2015 6:06


    Scott Huntington discusses the financial toxicity of oncology treatments

    Idiopathic thrombocytopenic purpura: The Lancet Haematology: July 29, 2015

    Play Episode Listen Later Jul 29, 2015 6:24


    James Bussel discusses a study looking at treatment options for children facing idiopathic thrombocytopenic purpura.

    INWORKS: The Lancet Haematology: June 29, 2015

    Play Episode Listen Later Jun 29, 2015 6:36


    Klervi Leuraud discusses a study reporting on the risk of developing leukaemia and lymphoma in workers monitored for radiation exposure.

    Warfarin: The Lancet Haematology: May 26, 2015

    Play Episode Listen Later May 26, 2015 12:05


    Páll Önundarson describes a new method for monitoring clotting in patients treated with warfarin, which they tested in a non-inferiority, randomised clinical trial.

    Claim In conversation with...

    In order to claim this podcast we'll send an email to with a verification link. Simply click the link and you will be able to edit tags, request a refresh, and other features to take control of your podcast page!

    Claim Cancel